Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects

被引:147
作者
Hatmal, Ma'mon M. [1 ]
Al-Hatamleh, Mohammad A. I. [2 ]
Olaimat, Amin N. [3 ]
Hatmal, Malik [4 ]
Alhaj-Qasem, Dina M. [5 ]
Olaimat, Tamadur M. [6 ]
Mohamud, Rohimah [2 ]
机构
[1] Hashemite Univ, Fac Appl Med Sci, Dept Med Lab Sci, Zarqa 13133, Jordan
[2] Univ Sains Malaysia, Sch Med Sci, Dept Immunol, Kubang Kerian 16150, Kelantan, Malaysia
[3] Hashemite Univ, Fac Appl Med Sci, Dept Clin Nutr & Dietet, Zarqa 13133, Jordan
[4] Prince Hamza Hosp, Amman 11947, Jordan
[5] Precis Med Lab, Amman 11954, Jordan
[6] Zarqa Univ, Fac Pharm, Zarqa 13132, Jordan
关键词
SARS-CoV-2; vaccine; COVID-19; post-vaccination symptoms; vaccine acceptance; vaccine hesitancy; vaccine anxiety; thrombocytopenia; thrombosis; blood clot; machine learning; PERSPECTIVES; WILLINGNESS; SARS-COV-2; INFECTION; VACCINES;
D O I
10.3390/vaccines9060556
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Since the coronavirus disease 2019 (COVID-19) was declared a pandemic, there was no doubt that vaccination is the ideal protocol to tackle it. Within a year, a few COVID-19 vaccines have been developed and authorized. This unparalleled initiative in developing vaccines created many uncertainties looming around the efficacy and safety of these vaccines. This study aimed to assess the side effects and perceptions following COVID-19 vaccination in Jordan. Methods: A cross-sectional study was conducted by distributing an online survey targeted toward Jordan inhabitants who received any COVID-19 vaccines. Data were statistically analyzed and certain machine learning (ML) tools, including multilayer perceptron (MLP), eXtreme gradient boosting (XGBoost), random forest (RF), and K-star were used to predict the severity of side effects. Results: A total of 2213 participants were involved in the study after receiving Sinopharm, AstraZeneca, Pfizer-BioNTech, and other vaccines (38.2%, 31%, 27.3%, and 3.5%, respectively). Generally, most of the post-vaccination side effects were common and non-life-threatening (e.g., fatigue, chills, dizziness, fever, headache, joint pain, and myalgia). Only 10% of participants suffered from severe side effects; while 39% and 21% of participants had moderate and mild side effects, respectively. Despite the substantial variations between these vaccines in the presence and severity of side effects, the statistical analysis indicated that these vaccines might provide the same protection against COVID-19 infection. Finally, around 52.9% of participants suffered before vaccination from vaccine hesitancy and anxiety; while after vaccination, 95.5% of participants have advised others to get vaccinated, 80% felt more reassured, and 67% believed that COVID-19 vaccines are safe in the long term. Furthermore, based on the type of vaccine, demographic data, and side effects, the RF, XGBoost, and MLP gave both high accuracies (0.80, 0.79, and 0.70, respectively) and Cohen's kappa values (0.71, 0.70, and 0.56, respectively). Conclusions: The present study confirmed that the authorized COVID-19 vaccines are safe and getting vaccinated makes people more reassured. Most of the post-vaccination side effects are mild to moderate, which are signs that body's immune system is building protection. ML can also be used to predict the severity of side effects based on the input data; predicted severe cases may require more medical attention or even hospitalization.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Public Willingness to Participate in COVID-19 Vaccine Clinical Trials: A Study from Jordan
    Abu-Farha, Rana K.
    Alzoubi, Karem H.
    Khabour, Omar F.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2451 - 2458
  • [2] COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
    Al-Hatamleh, Mohammad A. I.
    Hatmal, Ma'mon M.
    Alshaer, Walhan
    Rahman, Engku Nur Syafirah E. A.
    Mohd-Zahid, Manali Haniti
    Alhaj-Qasem, Dina M.
    Yean, Chan Yean
    Alias, Iskandar Z.
    Jaafar, Juhana
    Ferji, Khalid
    Six, Jean-Luc
    Uskokovic, Vuk
    Yabu, Hiroshi
    Mohamud, Rohimah
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 896
  • [3] Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions
    Al-Hatamleh, Mohammad A., I
    Hatmal, Ma'mon M.
    Sattar, Kamran
    Ahmad, Suhana
    Mustafa, Mohd Zulkifli
    Bittencourt, Marcelo De Carvalho
    Mohamud, Rohimah
    [J]. MOLECULES, 2020, 25 (21):
  • [4] Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
    Amit, Sharon
    Regev-Yochay, Gili
    Afek, Arnon
    Kreiss, Yitshak
    Leshem, Eyal
    [J]. LANCET, 2021, 397 (10277) : 875 - 877
  • [5] Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
    Sukrita Bhattacharjee
    Mainak Banerjee
    [J]. SN Comprehensive Clinical Medicine, 2020, 2 (11) : 2048 - 2058
  • [6] Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
    Carli, Giuseppe
    Nichele, Ilaria
    Ruggeri, Marco
    Barra, Salvatore
    Tosetto, Alberto
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 803 - 804
  • [7] Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
    Chapin-Bardales, Johanna
    Gee, Julianne
    Myers, Tanya
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21): : 2201 - 2202
  • [8] An Asia-Pacific study on healthcare workers' perceptions of, and willingness to receive, the COVID-19 vaccination
    Chew, Nicholas W. S.
    Cheong, Clare
    Kong, Gwyneth
    Phua, Kailun
    Ngiam, Jinghao Nicholas
    Tan, Benjamin Y. Q.
    Wang, Bokun
    Hao, Fengyi
    Tan, Wanqiu
    Han, Xiaofan
    Tran, Bach X.
    Men Thi Hoang
    Pham, Hai Q.
    Vu, Giang T.
    Chen, Yang
    Danuaji, Rivan
    Rn, Komalkumar
    Pv, Meenakshi
    Talati, Kalpesh
    Ho, Cyrus S.
    Sharma, Arvind K.
    Ho, Roger C.
    Sharma, Vijay K.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 106 : 52 - 60
  • [9] COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
    Chung, Young Hun
    Beiss, Veronique
    Fiering, Steven N.
    Steinmetz, Nicole F.
    [J]. ACS NANO, 2020, 14 (10) : 12522 - 12537
  • [10] Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study
    El-Shitany, Nagla A.
    Harakeh, Steve
    Badr-Eldin, Shaimaa M.
    Bagher, Amina M.
    Eid, Basma
    Almukadi, Haifa
    Alghamdi, Badrah S.
    Alahmadi, Ahlam A.
    Hassan, Nibal A.
    Sindi, Nariman
    Alghamdi, Samar A.
    Almohaimeed, Hailah M.
    Mohammedsaleh, Zuhair M.
    Al-Shaikh, Turki M.
    Almuhayawi, Mohammed S.
    Ali, Soad S.
    El-Hamamsy, Manal
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 1389 - 1401